PubMed (OMIM) for id: 651

Year	Number of Results
1970	1
1971	1
1972	2
1974	2
1975	1
1976	1
1977	2
1978	1
1980	2
1981	1
1982	1
1984	3
1985	2
1986	2
1987	1
1988	1
1989	2
1990	6
1991	2
1992	6
1997	1
1998	3
1999	2
2000	4
2001	5
2002	4
2003	6
2004	1
2005	1
2024	0

1

A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer.

Hopper JL, Hayes VM, Spurdle AB, Chenevix-Trench G, Jenkins MA, Milne RL, Dite GS, Tesoriero AA, McCredie MR, Giles GG, Southey MC. Hopper JL, et al. Hum Mutat. 2005 Oct;26(4):298-302. doi: 10.1002/humu.20237. Hum Mutat. 2005. PMID: 16121340

2

Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer.

Karppinen SM, Heikkinen K, Rapakko K, Winqvist R. Karppinen SM, et al. J Med Genet. 2004 Sep;41(9):e114. doi: 10.1136/jmg.2004.020669. J Med Genet. 2004. PMID: 15342711 Free PMC article. No abstract available.

3

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. King MC, et al. Science. 2003 Oct 24;302(5645):643-6. doi: 10.1126/science.1088759. Science. 2003. PMID: 14576434

4

Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor.

Kun Y, How LC, Hoon TP, Bajic VB, Lam TS, Aggarwal A, Sze HG, Bok WS, Yin WC, Tan P. Kun Y, et al. Hum Mol Genet. 2003 Dec 15;12(24):3245-58. doi: 10.1093/hmg/ddg347. Epub 2003 Oct 21. Hum Mol Genet. 2003. PMID: 14570715

5

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE. Haiman CA, et al. Hum Mol Genet. 2003 Oct 15;12(20):2679-92. doi: 10.1093/hmg/ddg294. Epub 2003 Aug 27. Hum Mol Genet. 2003. PMID: 12944421

6

The HLA class III subregion is responsible for an increased breast cancer risk.

de Jong MM, Nolte IM, de Vries EG, Schaapveld M, Kleibeuker JH, Oosterom E, Oosterwijk JC, van der Hout AH, van der Steege G, Bruinenberg M, Boezen HM, Te Meerman GJ, van der Graaf WT. de Jong MM, et al. Hum Mol Genet. 2003 Sep 15;12(18):2311-9. doi: 10.1093/hmg/ddg245. Epub 2003 Jul 22. Hum Mol Genet. 2003. PMID: 12915440

7

Puberty and genetic susceptibility to breast cancer in a case-control study in twins.

Hamilton AS, Mack TM. Hamilton AS, et al. N Engl J Med. 2003 Jun 5;348(23):2313-22. doi: 10.1056/NEJMoa021293. N Engl J Med. 2003. PMID: 12788995 Free article.

8

Molecular classification of familial non-BRCA1/BRCA2 breast cancer.

Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J. Hedenfalk I, et al. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2532-7. doi: 10.1073/pnas.0533805100. Epub 2003 Feb 27. Proc Natl Acad Sci U S A. 2003. PMID: 12610208 Free PMC article.

9

Heritability of mammographic density, a risk factor for breast cancer.

Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Boyd NF, et al. N Engl J Med. 2002 Sep 19;347(12):886-94. doi: 10.1056/NEJMoa013390. N Engl J Med. 2002. PMID: 12239257 Free article.

10

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.

Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA, Ambrosino C, Sauter G, Nebreda AR, Anderson CW, Kallioniemi A, Fornace AJ Jr, Appella E. Bulavin DV, et al. Nat Genet. 2002 Jun;31(2):210-5. doi: 10.1038/ng894. Epub 2002 May 20. Nat Genet. 2002. PMID: 12021785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year